tiprankstipranks
Trending News
More News >
Solvonis Therapeutics plc (GB:SVNS)
LSE:SVNS
UK Market

Solvonis Therapeutics (SVNS) Financial Statements

Compare
12 Followers

Solvonis Therapeutics Financial Overview

Solvonis Therapeutics's market cap is currently £20.42M. The company's EPS TTM is p0; its P/E ratio is ―; Solvonis Therapeutics is scheduled to report earnings on September 30, 2025, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue£ 0.00£ 587.00K£ 542.00K£ 219.00K£ 690.86K
Gross Profit£ 0.00£ -134.00K£ -51.00K£ 55.00K£ 517.72K
Operating Income£ -1.38M£ -3.12M£ -2.71M£ -845.00K£ -111.43K
EBITDA£ -1.38M£ -2.94M£ -2.59M£ -900.00K£ -322.29K
Net Income£ -1.59M£ -3.12M£ -2.71M£ -954.00K£ -274.29K
Balance Sheet
Cash & Short-Term Investments£ 757.00K£ 155.00K£ 1.64M£ 598.00K£ 209.00K
Total Assets£ 3.20M£ 2.43M£ 4.94M£ 3.13M£ 2.77M
Total Debt£ 0.00£ 34.00K£ 22.00K£ 950.00K£ 654.00K
Net Debt£ -757.00K£ -121.00K£ -1.62M£ 352.00K£ 445.00K
Total Liabilities£ 119.00K£ 408.00K£ 385.00K£ 2.32M£ 1.22M
Stockholders' Equity£ 3.08M£ 2.03M£ 4.55M£ 812.00K£ 1.54M
Cash Flow
Free Cash Flow£ -1.13M£ -1.47M£ -3.08M£ -255.00K£ -15.00K
Operating Cash Flow£ -1.13M£ -1.24M£ -2.36M£ -254.00K£ 1.00K
Investing Cash Flow£ -337.00K£ -232.00K£ -718.00K£ -1.00K£ -16.00K
Financing Cash Flow£ 2.08M£ 0.00£ 4.13M£ 800.00K£ 199.00K
Currency in GBP

Solvonis Therapeutics Earnings and Revenue History

Solvonis Therapeutics Debt to Assets

Solvonis Therapeutics Cash Flow

Solvonis Therapeutics Forecast EPS vs Actual EPS